| Investor Type | Firm |
| Stages | Early |
| Investing | United States |
The Center for Integration of Medicine & Innovative Technology (CIMIT) is a non-profit consortium consisting of Boston's leading teaching hospitals and universities. CIMIT facilitates interdisciplinary collaboration among world-class experts in translational research, medicine, science, and engineering, partnering with industry, foundations, and government to enhance patient care swiftly. With access to over 40,000 doctors and 20,000 technologists across consortium institutions, CIMIT is adept at sourcing and nurturing entrepreneurial clinicians and engineers.
Their mission includes providing these innovators with the necessary resources to explore, develop, and deploy novel technological solutions for healthcare's most critical challenges. CIMIT's early stage, collaborative research projects are particularly focused on the advancement of devices, procedures, diagnostics, and healthcare delivery methods.
Moreover, the CIMIT Accelerator grants aim to foster innovations likely to transition to industry within 12 to 18 months. On their website, CIMIT claims a significant role in driving the future of health innovation, indicating their contributions to the approval of the first rapid hepatitis C virus test for the U.S. market.
They also highlight various initiatives like the development of point-of-care technologies applicable in clinical settings and support of neurotech advancement. The CIMIT website details the impact they have had since 1998, supporting over 1,200 innovator teams and reviewing or consulting on more than 5,000 ideas.
They emphasize their goal of impacting patient care globally by working collaboratively with healthtech innovators, entrepreneurs, and institutions. By streamlining pathways to progress through efficient processes, established systems, and unmatched market expertise, CIMIT remains devoted to fostering medical technology advancements and improving health outcomes.









